Treatment patterns and costs for advanced GC vary in Mexico

Treatment patterns and costs for advanced GC vary in Mexico PharmacoEconomics & Outcomes News 784, p29 - 12 Aug 2017 Treatment patterns and costs for advanced GC vary in Mexico Treatment patterns and costs in patients with advanced or metastatic gastric cancer (GC) vary in Mexico, according to findings of an Eli Lilly and Company-affiliated chart review published in PharmacoEconomics - Open. Investigators reviewed Data Report File data for 180 adult patients at three tertiary centres who were diagnosed with advanced or metastatic GC between January 2009 and January 2015, received a first-line fluoropyrimidine and platinum regimen, and were followed up for at least 3 months after discontinuing first-line treatment. Direct medical costs were estimated from a payer perspective. In total, 16 first-line chemotherapy regimens and 19 second-line regimens were used. Overall, 83.9% of patients received second-line chemotherapy, 28.3% received third-line chemotherapy, and less than 10% of patients received over three lines of chemotherapy. Supportive care during in first- versus second-line chemotherapy included pain treatment (12.2% vs 7.9%), nutritional support (3.3% vs 1.3%), radiotherapy (6.1% vs 16.6%) and transfusions (13.3% vs 10.6%). Based on Mexican Institute of Social Security tariffs, the average total direct cost for first-line and second-line therapy was $1230 and $1192 per patient-month, respectively, primarily due to administration costs and drug acquisition costs. "Understanding GC treatment patterns in Mexico will help measure the impact of new innovations in treatment practice and create opportunities to harmonize treatment options," said the authors. * 2015 US dollars Quintana M, et al. Resources and Costs Associated with the Treatment of Advanced and Metastatic Gastric Cancer in the Mexican Public Sector: A Patient Chart Review. PharmacoEconomics-Open : 31 Jul 2017. Available from: URL: 803262565 1173-5503/17/0784-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved PharmacoEconomics & Outcomes News 12 Aug 2017 No. 784 PharmacoEconomics & Outcomes News Springer Journals

Treatment patterns and costs for advanced GC vary in Mexico

1 page

Loading next page...
1 Page
Springer International Publishing
Copyright © 2017 by Springer International Publishing AG
Medicine & Public Health; Pharmacoeconomics and Health Outcomes; Quality of Life Research; Health Economics; Public Health
Publisher site
See Article on Publisher Site

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches


Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.



billed annually
Start Free Trial

14-day Free Trial